[Nuclear medicine kidney diagnosis in progressive systemic scleroderma]

Area of Science:

• Nephrology
• Rheumatology
• Nuclear Medicine

Background:

• Kidney involvement is a common cause of mortality in progressive systemic scleroderma (PSS).
• Early detection of renal function impairment is vital for managing PSS patients.
• Nuclear medicine plays a role in assessing renal function.

Purpose of the Study:

• To evaluate the sensitivity of 131I-hippurate clearance compared to 99mTc-DMSA scans for detecting renal impairment in PSS patients.
• To establish the utility of hippurate clearance in the early diagnosis of kidney involvement in PSS.

Main Methods:

• A study was conducted on 76 patients with PSS undergoing nuclear medicine diagnostic procedures.
• Renal function was assessed using 131I-hippurate clearance and static 99mTc-DMSA scans.
• Pathologic results from both imaging modalities were compared.

Main Results:

• 131I-hippurate clearance identified 42 cases with abnormal renal function.
• Static 99mTc-DMSA scans detected only 14 abnormal results.
• Hippurate clearance demonstrated higher sensitivity in detecting renal impairment in PSS.

Conclusions:

• 131I-hippurate clearance is a highly sensitive method for evaluating renal function in patients with progressive systemic scleroderma.
• This nuclear medicine technique aids in the early detection of kidney involvement in PSS, potentially improving patient outcomes.